ResearcherNational Chung Hsing UniversityNo recent work listed

Yi‐Hao Hsu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5003541328. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. First author DOI 10.1002/ptr.7385 ↗
Pterostilbene Enhances Cytotoxicity and Chemosensitivity in Human Pancreatic Cancer Cells. Co-author DOI 10.3390/biom10050709 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gow‐Chin Yen · 2 shared papers, 2020–2022 · strength 0.33
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗
- Paper Pterostilbene Enhances Cytotoxicity and Chemosensitivity in Human Pancreatic Cancer Cells. DOI 10.3390/biom10050709 ↗
Sheng‐Yi Chen · 1 shared paper, 2022 · strength 0.19
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗
Ying‐Yin Chen · 1 shared paper, 2022 · strength 0.19
- Paper Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. DOI 10.1002/ptr.7385 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.